Shakir Mohamed K M, Spiro Andrew J, Mai Vinh Q, Hoang Thanh D
Division of Endocrinology, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
Case Rep Gastroenterol. 2020 Jul 30;14(2):391-401. doi: 10.1159/000508850. eCollection 2020 May-Aug.
Tumoral secretion of various molecular factors, such as calcitonin (Ct), can cause diarrhea in patients with medullary thyroid cancer (MTC). We report 3 patients (age 26-38 years, serum Ct levels ranging from 2,890 to 52,894 ng/L) with chronic diarrhea, and the diagnosis of MTC was delayed. Diarrheal symptoms improved after thyroid surgery. Two patients with elevated Ct had no diarrhea. The link between tumor humoral secretion and diarrhea is not well established in patients with MTC. Diarrhea is more common in patients with metastatic disease and improves after resection of the tumor. Diarrhea may result from elevated circulating levels of Ct or other substances, such as prostaglandins or serotonin. Other proposed mechanisms include decreased absorption in the colon secondary to gastrointestinal motor disturbances. In conclusion, MTC should be considered when evaluating chronic diarrhea.
甲状腺髓样癌(MTC)患者体内肿瘤分泌的各种分子因子,如降钙素(Ct),可导致腹泻。我们报告了3例(年龄26 - 38岁,血清Ct水平在2890至52,894 ng/L之间)患有慢性腹泻的患者,MTC的诊断被延迟。甲状腺手术后腹泻症状有所改善。2例Ct升高的患者未出现腹泻。MTC患者中肿瘤体液分泌与腹泻之间的联系尚未完全明确。腹泻在转移性疾病患者中更为常见,肿瘤切除后症状改善。腹泻可能是由于循环中Ct或其他物质(如前列腺素或5-羟色胺)水平升高所致。其他提出的机制包括继发于胃肠运动紊乱的结肠吸收减少。总之,在评估慢性腹泻时应考虑MTC。